Literature DB >> 32267926

Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.

Britt Christensen1,2,3, Stephen B Hanauer4, Peter R Gibson3, Jerrold R Turner5, John Hart1,6, David T Rubin1.   

Abstract

BACKGROUND AND AIMS: Complete histological normalisation and reduction of inflammation severity in patients with ulcerative colitis are associated with improved clinical outcomes, but the clinical significance of normalisation of only segments of previously affected bowel is not known. We examined the prevalence, pattern, predictors, and clinical outcomes associated with segmental histological normalisation in in patients with ulcerative colitis.
METHODS: Medical records of patients with confirmed ulcerative colitis and more than one colonoscopy were sought. Segmental histological normalisation was defined as histological normalisation of a bowel segment [rectum, left-sided or right-sided colon] that had previous evidence of chronic histological injury. We assessed the variables influencing these findings and whether segmental normalisation was associated with improved clinical outcomes.
RESULTS: Of 646 patients, 32% had segmental and 10% complete histological normalisaton when compared with their maximal disease extent. Most [88%] had segmental normalisation in a proximal-to-distal direction. Others had distal-to-proximal or patchy normalisation. On multivariate analysis, only current smoking [p = 0.040] and age of diagnosis ≤16 years [p = 0.028] predicted segmental histological normalisation. Of 310 who were in clinical remission at initial colonoscopy, 77 [25%] experienced clinical relapse after median 1.3 [range 0.06-7.52] years. Only complete histological normalisation of the bowel was associated with improved relapse-free survival (hazard ratio [HR] 0.23; 95% confidence interval [CI] 0.08-0.68; p = 0.008].
CONCLUSIONS: Segmental histological normalisation occurs in 32% of patients with ulcerative colitis and is increased in those who smoke or were diagnosed at younger age. Unlike complete histological normalisation, segmental normalisation does not signal improved clinical outcomes.
© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Histology; disease activity; disease regression; histological healing; mucosal healing

Mesh:

Substances:

Year:  2020        PMID: 32267926      PMCID: PMC7533894          DOI: 10.1093/ecco-jcc/jjaa068

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   10.020


  32 in total

1.  Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis.

Authors:  Marian C Aldhous; Hazel E Drummond; Niall Anderson; M Reza Baneshi; Linda A Smith; Ian D R Arnott; Jack Satsangi
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

2.  Changes in extent of ulcerative colitis: a study on the course and prognostic factors.

Authors:  E Langholz; P Munkholm; M Davidsen; O H Nielsen; V Binder
Journal:  Scand J Gastroenterol       Date:  1996-03       Impact factor: 2.423

3.  Non-smoking: a feature of ulcerative colitis.

Authors:  A D Harries; A Baird; J Rhodes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

4.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

5.  Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.

Authors:  Britt Christensen; Stephen B Hanauer; Jonathan Erlich; Olufemi Kassim; Peter R Gibson; Jerrold R Turner; John Hart; David T Rubin
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-24       Impact factor: 11.382

6.  Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time.

Authors:  C G Kleer; H D Appelman
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

7.  Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study.

Authors:  S M Samuelsson; A Ekbom; M Zack; C G Helmick; H O Adami
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

Review 8.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

9.  Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.

Authors:  Remo Panaccione; Subrata Ghosh; Stephen Middleton; Juan R Márquez; Boyd B Scott; Laurence Flint; Hubert J F van Hoogstraten; Annie C Chen; Hanzhe Zheng; Silvio Danese; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2014-02       Impact factor: 22.682

10.  Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients.

Authors:  R G Farmer; K A Easley; G B Rankin
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

View more
  3 in total

1.  Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis.

Authors:  Sushrut Jangi; Ariela K Holmer; Parambir S Dulai; Brigid Boland; Mark Valasek; Vipul Jairath; Brian G Feagan; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2021-02-06       Impact factor: 13.576

2.  PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis.

Authors:  Olga Maria Nardone; Alina Bazarova; Pradeep Bhandari; Rosanna Cannatelli; Marco Daperno; Jose Ferraz; Martin Goetz; Xianyong Gui; Bu Hayee; Gert De Hertogh; Mark Lazarev; Ji Li; Adolfo Parra-Blanco; Luca Pastorelli; Remo Panaccione; Vincenzo Occhipinti; Timo Rath; Samuel C L Smith; Uday N Shivaji; Gian Eugenio Tontini; Michael Vieth; Vincenzo Villanacci; Davide Zardo; Raf Bisschops; Ralf Kiesslich; Subrata Ghosh; Marietta Iacucci
Journal:  United European Gastroenterol J       Date:  2022-02-23       Impact factor: 4.623

Review 3.  Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?

Authors:  Panu Wetwittayakhlang; Livia Lontai; Lorant Gonczi; Petra A Golovics; Gustavo Drügg Hahn; Talat Bessissow; Peter L Lakatos
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.